148 related articles for article (PubMed ID: 20926112)
21. Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones.
Cihan-Üstündağ G; Zopun M; Vanderlinden E; Ozkirimli E; Persoons L; Çapan G; Naesens L
Bioorg Med Chem; 2020 Jan; 28(1):115130. PubMed ID: 31753804
[TBL] [Abstract][Full Text] [Related]
22. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
[TBL] [Abstract][Full Text] [Related]
23. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
Pabbaraju K; Ho KC; Wong S; Shokoples S; Pang XL; Fonseca K; Fox JD
Antiviral Res; 2008 Aug; 79(2):81-6. PubMed ID: 18258311
[TBL] [Abstract][Full Text] [Related]
24. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.
Simonsen L; Viboud C; Grenfell BT; Dushoff J; Jennings L; Smit M; Macken C; Hata M; Gog J; Miller MA; Holmes EC
Mol Biol Evol; 2007 Aug; 24(8):1811-20. PubMed ID: 17522084
[TBL] [Abstract][Full Text] [Related]
25. Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data.
Laplante JM; Marshall SA; Shudt M; Van TT; Reisdorf ES; Mingle LA; Shult PA; St George K
J Clin Microbiol; 2009 May; 47(5):1372-8. PubMed ID: 19321726
[TBL] [Abstract][Full Text] [Related]
26. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
[TBL] [Abstract][Full Text] [Related]
27. Biomimetic asymmetric total syntheses of spirooliganones A and B.
Song L; Yao H; Tong R
Org Lett; 2014 Jul; 16(14):3740-3. PubMed ID: 24971711
[TBL] [Abstract][Full Text] [Related]
28. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
[TBL] [Abstract][Full Text] [Related]
29. The origin and global emergence of adamantane resistant A/H3N2 influenza viruses.
Nelson MI; Simonsen L; Viboud C; Miller MA; Holmes EC
Virology; 2009 Jun; 388(2):270-8. PubMed ID: 19394063
[TBL] [Abstract][Full Text] [Related]
30. Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR Studies.
Chayrov R; Parisis NA; Chatziathanasiadou MV; Vrontaki E; Moschovou K; Melagraki G; Sbirkova-Dimitrova H; Shivachev B; Schmidtke M; Mitrev Y; Sticha M; Mavromoustakos T; Tzakos AG; Stankova I
Molecules; 2020 Sep; 25(17):. PubMed ID: 32883012
[TBL] [Abstract][Full Text] [Related]
31. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006.
Tang JW; Ngai KL; Wong JC; Lam WY; Chan PK
J Med Virol; 2008 May; 80(5):895-901. PubMed ID: 18360910
[TBL] [Abstract][Full Text] [Related]
32. Adamantane resistance in influenza A.
Weinstock DM; Zuccotti G
JAMA; 2006 Feb; 295(8):934-6. PubMed ID: 16493107
[No Abstract] [Full Text] [Related]
33. Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes.
Baranovich T; Bahl J; Marathe BM; Culhane M; Stigger-Rosser E; Darnell D; Kaplan BS; Lowe JF; Webby RJ; Govorkova EA
Antiviral Res; 2015 May; 117():10-9. PubMed ID: 25701593
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines.
Zoidis G; Kolocouris N; Kelly JM; Prathalingam SR; Naesens L; De Clercq E
Eur J Med Chem; 2010 Nov; 45(11):5022-30. PubMed ID: 20805012
[TBL] [Abstract][Full Text] [Related]
35. [Adamantan derivatives capable of inhibiting the reproduction of a Rimantadine resistant strain of influenza A(H1N1)pdm09 virus (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).].
Garaev TM; Odnovorov AI; Kirillova ES; Burtseva EI; Finogenova MP; Mukasheva EA; Grebennikova TV
Vopr Virusol; 2020; 65(1):16-20. PubMed ID: 32496716
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
[TBL] [Abstract][Full Text] [Related]
37. Heterocyclic rimantadine analogues with antiviral activity.
Zoidis G; Fytas C; Papanastasiou I; Foscolos GB; Fytas G; Padalko E; De Clercq E; Naesens L; Neyts J; Kolocouris N
Bioorg Med Chem; 2006 May; 14(10):3341-8. PubMed ID: 16439137
[TBL] [Abstract][Full Text] [Related]
38. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan.
Saito R; Suzuki Y; Li D; Zaraket H; Sato I; Masaki H; Kawashima T; Hibi S; Sano Y; Shobugawa Y; Oguma T; Suzuki H
J Infect Dis; 2008 Feb; 197(4):630-2; author reply 632-3. PubMed ID: 18275281
[No Abstract] [Full Text] [Related]
39. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
40. The relative potencies of anti-influenza compounds.
Tisdale M; Bauer DJ
Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
